TGFB1 and Sepsis: A potential third disorder in which TGF-β release may be involved was reported by Jude et al. [20], showing that inhibition of TGF-β1 in septic rats using the TGF-β inhibitor LY364947 protected the diaphragm muscle from sepsis-induced weakness and wasting.